AAAAAA

   
Results: 1-9 |
Results: 9
CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: RAHMAN Z KAVANAGH J CHAMPLIN R GILES R HANANIA E FU SQ ZU ZF MEHRA R HOLMES F KUDELKA A CLAXTON D VERSCHRAEGEN C GAJEWSKI J ANDREEFF M HEIMFELD S BERENSON R ELLERSON D CALVERT L MECHETNER E HOLZMAYER T DAYNE A HAMER J BACHIER C OSTROVE J PRZEPIORKA D BURTNESS B COTE R BAST R HORTOBAGYI G DEISSEROTH A
Citation: Z. Rahman et al., CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Clinical cancer research, 4(11), 1998, pp. 2717-2721
SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY)
Authors: ARCHIMBAUD E PHILIP I COIFFIER B MICHALLET M SALLES G SEBBAN C ROUBI N LOPEZ F BESSUEILLE L MAZARS P GERARD C HANANIA E RAMANATHAN R READING C JUTTNER C ATKINSON K PHILIP T
Citation: E. Archimbaud et al., SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY), Bone marrow transplantation, 21, 1998, pp. 52-52
CYTOSINE DEAMINASE ADENOVIRAL VECTOR AND 5-FLUOROCYTOSINE SELECTIVELYREDUCE BREAST-CANCER CELLS 1 MILLION-FOLD WHEN THEY CONTAMINATE HEMATOPOIETIC-CELLS - A POTENTIAL PURGING METHOD FOR AUTOLOGOUS TRANSPLANTATION
Authors: GARCIASANCHEZ F PIZZORNO G FU SQ NANAKORN T KRAUSE DS LIANG J ADAMS E LEFFERT JJ YIN LH COOPERBERG MR HANANIA E WANG WL WON JH PENG XY COTE R BROWN R BURTNESS B GILES R CRYSTAL R DEISSEROTH AB
Citation: F. Garciasanchez et al., CYTOSINE DEAMINASE ADENOVIRAL VECTOR AND 5-FLUOROCYTOSINE SELECTIVELYREDUCE BREAST-CANCER CELLS 1 MILLION-FOLD WHEN THEY CONTAMINATE HEMATOPOIETIC-CELLS - A POTENTIAL PURGING METHOD FOR AUTOLOGOUS TRANSPLANTATION, Blood, 92(2), 1998, pp. 672-682
RAPID HEMATOPOIETIC ENGRAFTMENT FOLLOWING TRANSPLANTATION OF PURIFIEDCD34-CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER(THY1+ STEM)
Authors: NEGRIN RS TIERNEY KD STOCKERLGOLDSTEIN KE HU WW SHIZURU JA JOHNSTON LJ ATKINSON K JUTTNER C SCHNELL J HANANIA E READING C RAMANATHAN R PETERS W BLUME KG KLEIN J
Citation: Rs. Negrin et al., RAPID HEMATOPOIETIC ENGRAFTMENT FOLLOWING TRANSPLANTATION OF PURIFIEDCD34-CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER(THY1+ STEM), Blood, 90(10), 1997, pp. 2635-2635
USE OF A SAFETY RECOMBINANT ADENOVIRUS VECTOR FOR SELECTIVE BONE-MARROW PURGING CARRYING THE CHEMOSENSITIZATION GENE CYTOSINE DEAMINASE
Authors: GARCIASANCHEZ F PIZZORNO G ADAMS E HANANIA E GILES R CRYSTAL R DEISSEROTH AB
Citation: F. Garciasanchez et al., USE OF A SAFETY RECOMBINANT ADENOVIRUS VECTOR FOR SELECTIVE BONE-MARROW PURGING CARRYING THE CHEMOSENSITIZATION GENE CYTOSINE DEAMINASE, Experimental hematology, 24(9), 1996, pp. 619-619
GENETIC-MODIFICATION OF CELLS USED FOR TRANSPLANT FOLLOWING INTENSIVETHERAPY FOR OVARIAN-CANCER ANP BREAST-CANCER
Authors: KAVANAGH J HANANIA E GILES R FU SQ ZU Z ELLERSON D WANG T CLAXTON D RAHMAN Z BERENSON R HEIMFELD S COTE R HOLZMAYER T MECHETNER E DAYNE A ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: J. Kavanagh et al., GENETIC-MODIFICATION OF CELLS USED FOR TRANSPLANT FOLLOWING INTENSIVETHERAPY FOR OVARIAN-CANCER ANP BREAST-CANCER, Blood, 88(10), 1996, pp. 1075-1075
MDR-1 VECTOR MARKING SHOWS THAT CFUGMS DO NOT CONTRIBUTE TO ENGRAFTMENT IN PATIENTS FOLLOWING INTENSIVE SYSTEMIC COMBINATION CHEMOTHERAPY
Authors: HANANIA E GILES R FU SQ ZU Z COTE R DAYN A WANG T ELLERSON D KAVANAGH J HOLZMAYER T MECHETNER E BERENSON R HEIMFELD S RAHMAN Z ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: E. Hanania et al., MDR-1 VECTOR MARKING SHOWS THAT CFUGMS DO NOT CONTRIBUTE TO ENGRAFTMENT IN PATIENTS FOLLOWING INTENSIVE SYSTEMIC COMBINATION CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2369-2369
CDNA FOR THE MULTIDRUG-RESISTANCE (MDR-1) GENE IN A TRANSCRIPTION UNIT OF A SAFETY MODIFIED RETROVIRUS CONFERS IN-VIVO RESISTANCE TO TAXOL ON EARLY PRECURSOR CELLS IN A MOUSE TRANSPLANT MODEL AND ON LONG-TERM CULTURE INITIATING CELLS IN LONG-TERM HUMAN MARROW CULTURE
Authors: HANANIA E FU S RONINSON I MECHETNER E HEGEWISCHBECKER S ANDREEFF M BERENSON R HEIMFELD S GOTTESMAN M DEISSEROTH A
Citation: E. Hanania et al., CDNA FOR THE MULTIDRUG-RESISTANCE (MDR-1) GENE IN A TRANSCRIPTION UNIT OF A SAFETY MODIFIED RETROVIRUS CONFERS IN-VIVO RESISTANCE TO TAXOL ON EARLY PRECURSOR CELLS IN A MOUSE TRANSPLANT MODEL AND ON LONG-TERM CULTURE INITIATING CELLS IN LONG-TERM HUMAN MARROW CULTURE, Blood, 82(10), 1993, pp. 10000216-10000216
RETROVIRAL MARKING STUDIES SHOW THAT INFUSED EXOGENOUS MARROW-CELLS GIVE RISE TO HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS TRANSPLANT, AND THAT RELAPSE AFTER AUTOLOGOUS TRANSPLANT IN CML MAY ARISE FROM PH+ CELLSPRESENT IN MARROW AT THE TIME OF TRANSPLANT
Authors: DEISSEROTH A ZU Z CLAXTON D HANANIA E BERENSON R HEIMFELD S BRENNER M MOEN R ANDERSON WF TALPAZ M HAMER J CALVERT L ELLERSON D GOLDBERG L JANICEK K THOMAS M KANTARJIAN H CHAMPLIN R READING C
Citation: A. Deisseroth et al., RETROVIRAL MARKING STUDIES SHOW THAT INFUSED EXOGENOUS MARROW-CELLS GIVE RISE TO HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS TRANSPLANT, AND THAT RELAPSE AFTER AUTOLOGOUS TRANSPLANT IN CML MAY ARISE FROM PH+ CELLSPRESENT IN MARROW AT THE TIME OF TRANSPLANT, Blood, 82(10), 1993, pp. 10000454-10000454
Risultati: 1-9 |